AEON Stock Summary and Trading Ideas (Aeon Biopharma Class A | AMEX:AEON)

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Aeon Biopharma Class A trades on the AMEX stock market under the symbol AEON.

As of April 22, 2026, AEON stock price climbed to $1.09 with 52,148 million shares trading.

AEON has a beta of 0.16, meaning it tends to be less sensitive to market movements. AEON has a correlation of 0.00 to the broad based SPY ETF.

AEON has a market cap of $27.58 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that AEON belongs to (by Net Assets): VXF.

AEON has outperformed the market in the last year with a price return of +169.1% while the SPY ETF gained +36.3%. However, in the short term, AEON had mixed performance relative to the market. It has underperformed in the last 3 months, returning -6.8% vs +3.5% return in SPY. But in the last 2 weeks, AEON shares have fared better than the market returning +21.1% compared to SPY +5.2%.

AEON support price is $1.02 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEON shares will trade within this expected range on the day.